COVID-19 vaccination in Portugal

Last updated
COVID-19 vaccination in Portugal
Official Name
Organized by Task-Force COVID-19: Ministério da Saúde, Direção-Geral da Saúde, Exército Português, Infarmed, SPMS, Ministério da Administração Interna
General Information
TypeNational level COVID-19 vaccination campaign
LocationFlag of Portugal.svg  Portugal
Date27 December 2020 (1 year, 1 month and 8 days)

Vaccination against COVID-19 in Portugal started on 27 December 2020.

The Government of Portugal appointed a task force on 18 November 2020 to develop the COVID-19 Vaccination Plan. [1] The COVID-19 Vaccination Plan Task Force was formalised on 23 November 2020. It was led by Francisco Ramos, former Undersecretary of State and Health, and composed of military personnel, technicians from the Shared Services of the Ministry of Health (SPMS), the General Directorate of Health and Infarmed. In 30 days, on 18 December, the task force presented the plan, which divided the vaccination into three phases, according to the priority of the people to be vaccinated. [2]

Approval of vaccines within the European Union is done by the European Medicines Agency (EMA), and the first COVID-19 vaccine, Tozinameran from Pfizer/BioNTech, was approved on 21 December 2020. In concert with other EU countries, Portugal began vaccination on 27 December, followed by vaccination of healthcare professionals directly in contact with COVID patients. The first Portuguese to be vaccinated was António Sarmento, director of the infectious diseases department at the Hospital de São João. [3]

Portugal stands out internationally as one of the countries with the highest percentage of vaccinated population: with data as of 11 October 2021 88% of the country's total population has received the first dose. [4] Portugal also has the highest level of COVID-19 vaccination within the European Union as of the end of September 2021. [5]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

Pfizer–BioNTech Green check.svg 21 December 2020Green check.svg 27 December 2020
Moderna Green check.svg 6 January 2021Green check.svg 12 January 2021
Oxford-AstraZeneca Green check.svg 29 January 2021Green check.svg 7 February 2021
Janssen Green check.svg 11 March 2021Green check.svg Yes
Novavax Green check.svg 20 December 2021Pending
Valneva PendingPending
Sanofi–GSK PendingPending
CureVac Cancelled process mini.svg Request withdrawnDark Red x.svg No

Related Research Articles

Vaccination policy is a kind of health policy that governments adopt in order to prevent the spread of infectious disease through vaccination. A wide variety of vaccination policies have been developed over the approximately two centuries since the invention of vaccination with the purpose of creating herd immunity, or eradicating a disease altogether, for the population the government aims to protect. Vaccination advisory committees within each country are usually responsible for providing information to governments that is used to make evidence-based decisions regarding vaccine and immunization policy.

COVID-19 vaccine Vaccine designed to provide acquired immunity against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).

Sputnik V COVID-19 vaccine Vaccine against COVID-19

Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.

Vaccination requirements for international travel are the aspect of vaccination policy that concerns the movement of people across borders. Countries around the world require travellers departing to other countries, or arriving from other countries, to be vaccinated against certain infectious diseases in order to prevent epidemics. At border checks, these travellers are required to show proof of vaccination against specific diseases; the most widely used vaccination record is the International Certificate of Vaccination or Prophylaxis. Some countries require information about a passenger's vaccination status in a passenger locator form.

COVID-19 vaccination in Switzerland Plan to immunize against COVID-19

COVID-19 vaccination in Switzerland is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Sweden

Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 17 December 2021, 85.3% of people in Sweden have received at least one dose, with a total of 17,049,272 doses administered.

COVID-19 vaccination in Israel

Israel's COVID-19 vaccination programme, officially named "Give a Shoulder", began on 19 December 2020, and has been praised for its speed, having given twenty percent of the Israeli population the first dose of the vaccines' two dose regimen in the span of three weeks.

Deployment of COVID-19 vaccines Distribution and administration of COVID-19 vaccinations

As of 1 February 2022, 10.1 billion COVID-19 vaccine doses have been administered worldwide, with 61.1 percent of the global population having received at least one dose. While 22.77 million vaccines were then being administered daily, only 10 percent of people in low-income countries had received at least a first vaccine by January 2022, according to official reports from national health agencies, which are collated by Our World in Data.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

COVID-19 vaccination in the Republic of Ireland Immunisation plan against COVID-19

The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and was ranked number one in the European Union in terms of its percentage of adult population fully vaccinated, and was also ranked number one in the EU for the number of booster vaccines administered.

COVID-19 vaccination in the United States Plan to immunize against COVID-19

The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020; mass vaccinations began on December 14, 2020. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen vaccine was granted emergency use authorization on February 27, 2021. By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over.

COVID-19 vaccination in New Zealand Ongoing COVID-19 vaccine programme in New Zealand

COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the pandemic with the goal of vaccinating all willing New Zealanders aged 5 or older. Those aged 5 to 11 require a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated. As of 1 September, anyone in New Zealand, regardless of their immigration status, is eligible to be vaccinated.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered.

COVID-19 vaccination in Brazil

The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.

COVID-19 vaccine card Medical record for COVID-19 vaccination

A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received the shot(s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given. Depending on the country, it could serve as an official document verifying one has received vaccination, which could be required by some institutions, such as a school or workplace, when boarding a cruise ship, or when crossing an international border, as proof that one has been vaccinated.

COVID-19 vaccination in Spain Immunization plan against COVID-19 in Spain

The COVID-19 vaccination in Spain is the national vaccination strategy started on the 27th of December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.

COVID-19 vaccination in Ukraine Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

Henrique Gouveia e Melo Portuguese naval officer

Admiral Henrique Eduardo Passaláqua de Gouveia e Melo is a Portuguese Navy officer, currently serving as the Chief of the Naval Staff, since December 2021.

Vaccine passports during the COVID-19 pandemic Use of immunity passports for COVID-19 vaccination

A vaccine passport or proof of vaccination is an immunity passport employed as a credential in countries and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health authority, and usually consists of a digital or printed record. Some credentials may include a scannable QR code, which can also be provisioned via mobile app. It may or may not use a COVID-19 vaccine card as a basis of authentication.


  1. "Portugal sets up taskforce to prepare COVID-19 vaccine distribution". Euractiv . 19 November 2020. Retrieved 20 November 2021.
  2. "O plano da vacinação anticovid: dos sms aos utentes à segurança no transporte". Diário de Notícias . 18 December 2020.
  3. Lusa, Daniel Rocha, Paulo Pimenta. "Covid-19: as imagens do primeiro dia de vacinação em Portugal". PÚBLICO.
  4. Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; Macdonald, Bobbie; Beltekian, Diana; Roser, Max (March 5, 2020). "Coronavirus Pandemic (COVID-19)". Our World in Data via
  5. Kottasová, Ivana (1 October 2021). "They have all the vaccines they need, yet these EU nations are still miles behind their neighbors". CNN. Archived from the original on 2021-10-01. Retrieved 2021-10-01.